RTS, S Malaria vaccination-Its efficacy and use on the public grounds!!!
Malaria is one of the most common infectious diseases. Hence, when there is the stagnant water present anywhere near the house, the people who are living nearby shall get ready for the malaria attack. The reason is that the stagnant water is the breeding grounds for the vector of malaria. Hence, on the municipality levels in many parts of the world, measures are being taken to drain the water. On the other hand, the prevention has also been introduced in the people through the use of vaccinations which can be done on the public levels. Among such vaccination include the RTS, S Malaria vaccination which is being done in Africa and there are great outcomes through its use.
According to the results through the use of the RTS, S Malaria vaccination on the phase III trials, there is the great deal of protection that is obtained in many patients in Africa. Among the age group that is mostly treated through the use of RTS, S Malaria vaccination includes the children of age group between 5 to 17 months. Not only there is the great efficacy for this drug, but there is the great tolerability that has been reported among the patients. Therefore, there are no worries for the anaphylactic reactions for the children who are going to use it. According to the statistics, nearly 800, 000 people around the world die due to malaria. Hence, there is the great awareness program that is needed in order to save the people on such a high scale.
To check the efficacy for the RTS, S Malaria vaccination, the trial was done in seven countries in Africa, and these are all situated in the sub-Saharan Africa when malaria is present on the endemic basis. Therefore, the use of RTS, S Malaria vaccination for the immunization of the people is the good idea. With the 3 doses that are being used in the people, people who have the severe malaria were saved with the ratio of 56%, while the patients who have the moderate malaria, have the success rate of 47%. Among the complications that are being checked with the use of RTS, S Malaria vaccination, it was minimal. According to the makers of RTS, S Malaria vaccination, the long term efficacy type for this is being developed. There is the wide window of safety that is reported with the use of RTS, S Malaria vaccination including the complications being reported in only 22% of the patients.
